
mdCurrent Conference Report: 64th American Academy of Neurology Annual Meeting Data from 2 major phase 3 trials have demonstrated that progression to clinically definite multiple sclerosis (MS) can be prevented or delayed with early rather than delayed therapy. Two regimens of subcutaneous interferon beta-1a (IFNb) were evaluated in patients who…
Read more »
Hormone replacement therapy may increase the risk of ulcerative colitis in postmenopausal women
mdCurrent Conference Report: Digestive Disease Week Hormone replacement therapy (HRT) may increase the risk of ulcerative colitis in postmenopausal women, according to a new study presented at Digestive Disease Week 2012. “It is important that clinicians are aware of the results of this study, but it should not lead to…
Read more »